Skip to content

Patency rate between Drug-Coated Balloon and Plain Balloon Angioplasty in Autologous Arteriovenous Fistula or Prosthetic Arteriovenous Graft

Patency rate between Drug-Coated Balloon and Plain Balloon Angioplasty in Autologous Arteriovenous Fistula or Prosthetic Arteriovenous Graft

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20220117001
Enrollment
60
Registered
2022-01-17
Start date
2016-08-08
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis access problem Patency of the hemodialysis access treatment Hemodialysis access Arteriovenous fistula Chronic kidney disease Drug coated balloon

Interventions

The patients who had a hemodialysis access problem and treated with the plain balloon method.,The patients who had a hemodialysis access problem and treated solely with the drug-coated balloon method.
Plain Balloon ,Drug coated balloon group

Sponsors

No
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Chronic kidney disease patients who required treatment of their hemodialysis access.

Exclusion criteria

Exclusion criteria: Patients who are allergic to contrast media or iodine. Patients who are refusing to participate in this study.

Design outcomes

Primary

MeasureTime frame
Patency of the hemodialysis access 9 months The duplex ultrasound was used to evaluate the treated segment and duration of re-intervention.

Secondary

MeasureTime frame
Factor associate with the re-stenosis of the hemodialysis access 9 months Cox-regression model

Countries

Thailand

Contacts

Public ContactThoetphum Benyakorn

Thammasat Medical School

thoetben@tu.ac.th0818080810

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026